Patel Sanjiv

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$500,000.00
Insider Sells Quantity
13
Insider Sells Sum
$4.68M

Insider Activity of Patel Sanjiv

According to the SEC Form 4 filings, Patel Sanjiv, being in a position of

  1. President and CEO at Relay Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 186706 shares for $1.29M,
    over all time since 2020-07-20, has bought 50000 shares for $500,000, and sold 336531 share for $4.68M.

The largest purchase of all time was on 2020-07-20 and amounted to 50000 shares of Relay Therapeutics, Inc. for $500,000.

The largest sale of all time was on 2023-01-19 and amounted to 28000 shares of Relay Therapeutics, Inc. for $560,560.

Biography of Patel Sanjiv

No biography is available at this moment.

2024-12-16SaleRelay Therapeutics, Inc.
RLAY
President and CEO
100,000
0.0623%
$5.00$500,000-10.33%
2024-07-26SaleRelay Therapeutics, Inc.
RLAY
President and CEO
36,706
0.0281%
$9.07$332,923-27.4%
2024-07-25SaleRelay Therapeutics, Inc.
RLAY
President and CEO
50,000
0.0381%
$9.16$458,000-28.37%
2023-02-09SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.0118%
$20.55$287,700-45.34%
2023-02-08SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.0119%
$20.98$293,720-45.97%
2023-02-07SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.0116%
$21.45$300,300-48.31%
2023-01-19SaleRelay Therapeutics, Inc.
RLAY
President and CEO
28,000
0.0229%
$20.02$560,560-44.42%
2022-11-10SaleRelay Therapeutics, Inc.
RLAY
President and CEO
9,825
0.0088%
$20.00$196,500-38.86%
2022-10-13SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.0125%
$20.58$288,120-29.64%
2022-09-15SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.012%
$23.80$333,200-37.18%
2022-09-14SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.0124%
$23.47$328,580-34.17%
2022-09-13SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.0134%
$25.45$356,300-34.04%
2022-04-12SaleRelay Therapeutics, Inc.
RLAY
President and CEO
14,000
0.0132%
$31.94$447,160-38.22%
2020-07-20PurchaseRelay Therapeutics, Inc.
RLAY
President and CEO
50,000
0.0164%
$10.00$500,000-11.36%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.